BIOMAT Database Logo BIOMAT Database Logo

Allopurinol: xanthine oxidase inhibitor. 1966

J N Delgado, and F P Cosgrove, and E I Isaacson

UI MeSH Term Description Entries
D006073 Gout Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi. Gouts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014969 Xanthine Oxidase An iron-molybdenum flavoprotein containing FLAVIN-ADENINE DINUCLEOTIDE that oxidizes hypoxanthine, some other purines and pterins, and aldehydes. Deficiency of the enzyme, an autosomal recessive trait, causes xanthinuria. Hypoxanthine Oxidase,Hypoxanthine Dehydrogenase,Hypoxanthine-Xanthine Oxidase,Purine-Xanthine Oxidase,Dehydrogenase, Hypoxanthine,Hypoxanthine Xanthine Oxidase,Oxidase, Hypoxanthine,Oxidase, Hypoxanthine-Xanthine,Oxidase, Purine-Xanthine,Oxidase, Xanthine,Purine Xanthine Oxidase
D057487 Enzyme Therapy The use of enzymes to correct metabolic and physiological processes. Enzymotherapy,Systemic Enzyme Therapy,Enzyme Therapies,Enzyme Therapies, Systemic,Enzyme Therapy, Systemic,Enzymotherapies,Systemic Enzyme Therapies,Therapies, Enzyme,Therapies, Systemic Enzyme,Therapy, Enzyme,Therapy, Systemic Enzyme

Related Publications

J N Delgado, and F P Cosgrove, and E I Isaacson
Metabolic studies of allopurinol, an inhibitor of xanthine oxidase.
July 1966, Biochemical pharmacology,
J N Delgado, and F P Cosgrove, and E I Isaacson
Xanthine toxicity to caterpillars synergized by allopurinol, a xanthine dehydrogenase/oxidase inhibitor.
November 1993, Journal of chemical ecology,
J N Delgado, and F P Cosgrove, and E I Isaacson
Allopurinol (xanthine oxidase inhibitor) in the treatment of resistant gout.
November 1966, JAMA,
J N Delgado, and F P Cosgrove, and E I Isaacson
Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy.
August 2009, Journal of cellular and molecular medicine,
J N Delgado, and F P Cosgrove, and E I Isaacson
The anti-inflammatory action of a xanthine oxidase inhibitor (allopurinol).
January 1969, Pharmacology,
J N Delgado, and F P Cosgrove, and E I Isaacson
Treatment of uric acid urolithiasis with allopurinol: a xanthine oxidase inhibitor.
February 1967, The Journal of urology,
J N Delgado, and F P Cosgrove, and E I Isaacson
Allopurinol, xanthine oxidase, and cardiac ischemia.
December 2009, Journal of investigative medicine : the official publication of the American Federation for Clinical Research,
J N Delgado, and F P Cosgrove, and E I Isaacson
The antinociceptive and anti-exudative action of a xanthine oxidase inhibitor (allopurinol) and of xanthine.
January 1971, Pharmacology,
J N Delgado, and F P Cosgrove, and E I Isaacson
The inhibition of tryptophan pyrrolase by allopurinol, an inhibitor of xanthine oxidase.
November 1967, Canadian journal of biochemistry,
J N Delgado, and F P Cosgrove, and E I Isaacson
Effect of a xanthine-oxidase inhibitor (allopurinol) on radioiron absorption in man.
August 1966, Lancet (London, England),
Copied contents to your clipboard!